Metastatic Foci Formation
Metastatic Foci Formation - Related Videos
04:09
Assessing DNA Damage Foci: To Identify Radiation-Induced DNA Damage Foci in Cancer Cell Line Using Immunofluorescence Staining
0 Views •
2023
This video describes a protocol to detect radiation-induced DNA repair foci in the colon cancer cell lines using immunofluorescence staining. DNA repair proteins get activated at the DNA damage site; therefore, we can detect them using specific antibodies and visualize them under a fluorescence microscope.
03:52
Experimental Metastatic Melanoma Mouse Model: A Platform to Study the Metastatic Potential of Melanoma Cells in the Lungs
0 Views •
2023
In this video, melanoma cells are intravenously injected through the tail vein in the mouse model. The melanoma cells further travel through the circulatory system, adapting to the distant microenvironment and causing metastasis in organs like lungs.
08:48
Quantitation of γH2AX Foci in Tissue Samples
0 Views •
Cited by 7 •
2010
Quantitation of DNA double-strand breaks on the basis of γH2AX foci has become an invaluable tool, particularly in radiation biology, for the evaluation of tissue radiosensitivity and effects of radiation modifying compounds. Here we demonstrate the use of an immunofluorescence assay for quantitation of γH2AX foci in tissue samples.
07:31
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
0 Views •
Cited by 13 •
2016
Metastasis plays a profound role in the virulence of cancer, accounting for an estimated 90% of deaths. We report a protocol for a metastatic melanoma model in mice that is useful for determining the efficacy of therapeutic agents against this clinical phenomenon.
06:53
Quantification of γH2AX Foci in Response to Ionising Radiation
0 Views •
Cited by 23 •
2010
Quantification of DNA double-strand streaks using γH2AX formation as a molecular marker has become an invaluable tool in radiation biology. Here we demonstrate the use of an immunofluorescence assay for quantification of γH2AX foci after exposure of cells to radiation.
FAQs
Successful colonization requires more than movement away from the primary tumor. Cancer cells must invade locally, enter blood or lymphatic vessels, survive dissemination, exit into another tissue, and adapt to its microenvironment. Failure at any stage can prevent a detectable focus from developing, making the sequence useful for identifying stage-specific mechanisms and therapeutic targets.
Organ preference reflects the interaction between disseminated cancer cells and the microenvironment of potential target tissues. The overview identifies tissue adaptation and molecular pathways supporting colonization as important factors. Studying these relationships can help explain why secondary lesions are not distributed randomly and can reveal tissue-specific conditions that permit metastatic growth.
Stromal and immune cells are part of the tissue context that disseminated cancer cells must navigate and adapt to. Their interactions with tumor cells may influence survival, establishment, and expansion of secondary lesions. Cancer research examines these cellular relationships to clarify how the microenvironment supports or limits metastatic foci formation and to identify intervention points.
After extravasation, disseminated cells must adapt to the new tissue microenvironment before they can proliferate into detectable lesions. Molecular pathways that support this adaptation and colonization therefore become central targets of investigation. Characterizing them helps distinguish simple dissemination from productive metastatic growth and may guide the development of approaches intended to reduce secondary disease.
Experimental models reproduce or assess aspects of metastatic disease so investigators can examine how secondary tumor sites arise and develop. They support analysis of metastatic mechanisms, tumor interactions with stromal and immune cells, and the conditions associated with tissue colonization. These models also provide a framework for evaluating biomarkers and therapies directed against metastatic disease.
Biomarker evaluation can help researchers identify signals associated with metastatic progression or the establishment of secondary lesions. Within metastatic foci models, such analysis connects measurable molecular features with processes such as dissemination, tissue adaptation, and colonization. The resulting information may improve understanding of disease behavior and help assess whether candidate biomarkers are useful in cancer research.
These models allow investigators to examine whether a therapy prevents or reduces metastatic disease rather than focusing only on the primary tumor. Outcomes can be considered in relation to the stages of dissemination and colonization represented in the model. This makes them valuable for comparing treatment effects and identifying approaches that interfere with secondary tumor-site establishment.